Abstract
A series of 6-diethylaminoquinazolin-4(3H)-ones with bulky aryl rings at C2 were designed to cover the vacant space of ligand binding pocket of topoisomerase (topo) I-DNA complex. The desired derivatives were synthesized by thermal cyclodehydration/ dehydrogenation reactions of 5-diethylaminoanthranilamide with substituted aromatic aldehydes. The cytotoxicity of these compounds was evaluated against human epidermoid carcinoma (KB), hepatocellular carcinoma (Hep-G2), human lung carcinoma (LU-1) and human breast carcinoma cells (MCF-7). Most of the synthesized compounds exhibited more potent cytotoxicity than the standard anticancer agent, ellipticine. Among the tested compounds, quinazolinone 1l was the most cytotoxic against all cancer cell lines (IC50: 0.02–0.08 µM). Docking study showed that the new 2-aryl-6- diethylaminoquinazolinones possibly inhibit topo I activities to exhibit anticancer properties.
Keywords: 2-Aryl-6-diethylaminoquinazolinone, 3-arylisoquinoline, bioisosteres, anticancer activity, topoisomerase inhibition.
Letters in Drug Design & Discovery
Title:Synthesis and Anticancer Activity of 2-Aryl-6-diethylaminoquinazolinone Derivatives
Volume: 13 Issue: 7
Author(s): Thanh Nguyen Le, Daulat Bikram Khadka, Giap Huu Tran, Dung Anh Nguyen, Yifeng Jin, Hue Thi My Van, Van Hung Nguyen and Won-Jea Cho
Affiliation:
Keywords: 2-Aryl-6-diethylaminoquinazolinone, 3-arylisoquinoline, bioisosteres, anticancer activity, topoisomerase inhibition.
Abstract: A series of 6-diethylaminoquinazolin-4(3H)-ones with bulky aryl rings at C2 were designed to cover the vacant space of ligand binding pocket of topoisomerase (topo) I-DNA complex. The desired derivatives were synthesized by thermal cyclodehydration/ dehydrogenation reactions of 5-diethylaminoanthranilamide with substituted aromatic aldehydes. The cytotoxicity of these compounds was evaluated against human epidermoid carcinoma (KB), hepatocellular carcinoma (Hep-G2), human lung carcinoma (LU-1) and human breast carcinoma cells (MCF-7). Most of the synthesized compounds exhibited more potent cytotoxicity than the standard anticancer agent, ellipticine. Among the tested compounds, quinazolinone 1l was the most cytotoxic against all cancer cell lines (IC50: 0.02–0.08 µM). Docking study showed that the new 2-aryl-6- diethylaminoquinazolinones possibly inhibit topo I activities to exhibit anticancer properties.
Export Options
About this article
Cite this article as:
Le Nguyen Thanh, Khadka Bikram Daulat, Tran Huu Giap, Nguyen Anh Dung, Jin Yifeng, Van Thi My Hue, Nguyen Hung Van and Cho Won-Jea, Synthesis and Anticancer Activity of 2-Aryl-6-diethylaminoquinazolinone Derivatives, Letters in Drug Design & Discovery 2016; 13 (7) . https://dx.doi.org/10.2174/1570180813666160125222936
DOI https://dx.doi.org/10.2174/1570180813666160125222936 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Interaction and Cytotoxic Effects of Hydrophobized Chitosan Nanoparticles on MDA-MB-231, HeLa and Arpe-19 Cell Lines
Current Topics in Medicinal Chemistry Pharmacological Inhibition of Poly(ADP-ribose) Polymerase (PARP) Activity in PARP-1 Silenced Tumour Cells Increases Chemosensitivity to Temozolomide and to a N3-Adenine Selective Methylating Agent
Current Cancer Drug Targets Target Fishing of Calactin, Calotropin and Calotoxin Using Reverse Pharmacophore Screening and Consensus Inverse Docking Approach
Current Drug Discovery Technologies Heterocyclic Dications as a New Class of Telomeric G-Quadruplex Targeting Agents
Current Pharmaceutical Design Treatment with Radix Euphorbiae Ebracteolatae Significantly Decreases the Expression of E6 and L1, and Increases the Expression of p53 and Rb in HPV18-infected Human Foreskin Keratinocytes
Current Molecular Medicine Use of Anticancer Platinum Compounds in Combination Therapies and Challenges in Drug Delivery
Current Medicinal Chemistry RNA Interference: A New Targeted Tumour Therapy?
Current Cancer Therapy Reviews The Regulatory Functions of a New Tetrapeptide from the Bursa of Fabricius on AIV Vaccine Immunization and Antibody Production
Protein & Peptide Letters The Correspondence Between Magnetic Resonance Images and the Clinical and Intraoperative Status of Patients with Spinal Tumors
Current Medical Imaging Dendritic Cells and the Promise of Therapeutic Vaccines for Human Immunodeficiency Virus (HIV)-1
Current HIV Research Status of Anti-Lung Cancer Drug Patents Applications in China from 2003 to 2012
Recent Patents on Anti-Cancer Drug Discovery Purification and Characterization of a Lectin of the Swartzieae Legume Taxa
Protein & Peptide Letters Lessons from Viruses: Controlling the Function of Transmembrane Proteins by Interfering Transmembrane Helices
Current Medicinal Chemistry Multifunctional Nanoparticles, Nanocages and Degradable Polymers as a Potential Novel Generation of Non-Invasive Molecular and Cellular Imaging Systems
Recent Patents on Nanotechnology Structure-Activity Relationship Studies on Holy Basil (Ocimum sanctum L.) Based Flavonoid Orientin and its Analogue for Cytotoxic Activity in Liver Cancer Cell Line HepG2
Combinatorial Chemistry & High Throughput Screening Theoretical Modeling of HPV: QSAR and Novodesign with Fragment Approach
Current Computer-Aided Drug Design Functionalized Nanocarriers for Enhanced Bioactive Delivery to Squamous Cell Carcinomas: Targeting Approaches and Related Biopharmaceutical Aspects
Current Pharmaceutical Design Dual Roles of Pin1 in Cancer Development and Progression
Current Pharmaceutical Design Phytochemicals Resveratrol and Sulforaphane as Potential Agents for Enhancing the Anti-Tumor Activities of Conventional Cancer Therapies
Current Pharmaceutical Biotechnology Alpha-1 Antitrypsin: It’s Role in Health and Disease
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry